Clinical trial

Study Of 323U66 SR In Major Depressive Disorder

NCT00135512

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2004-12-01

PhasePHASE2

Study timeline

Study start (actual)2004-12-01Date precision: day

Registry last updated2019-02-01

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Depressive Disorderunresolved

Interventions

bupropion hydrochlorideDRUG · verified · RxNorm: bupropion hydrochloride

Sponsors & collaborators

GlaxoSmithKlinelead sponsor

Mapped research locations

TokyoJapan1 FukuokaJapan1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00135512 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.